| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.003 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |